Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL

Blood (2025) 146 (Supplement 1): 648.

https://doi.org/10.1182/blood-2025-648

Published: 2025

Journal Articles

Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 646.

https://doi.org/10.1182/blood-2025-646

Published: 2025

Journal Articles

An evaluation of the relationship between abnormal myocardial perfusion and diastolic dysfunction in sickle cell disease using PET rest-stress myocardial perfusion imaging: Mypers

Parul Rai, R Morrison, Kendria Barnes, Sarra O'Bryan, Tomas Bryndziar, Yimei Li, Laurie Shoulders, Amy Vavere, Devendra Sawant, Jason Johnson, Barry Shulkin, Anthony Merlocco

Blood (2025) 146 (Supplement 1): 1199.

https://doi.org/10.1182/blood-2025-1199

Published: 2025

Journal Articles

Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2025-2848

Published: 2025

Journal Articles

Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation

Blood (2025) 146 (Supplement 1): 876.

https://doi.org/10.1182/blood-2025-876

Published: 2025

Journal Articles

Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 study

Abigale Berry, Caitlin Elgarten, Yimei Li, Hongyan Liu, Katherine Lind, Daniel Zheng, Gabriella Nguyen, Vanessa Fabrizio, Maria Ortega, Jeremy Rubinstein, Troy Quigg, Anurekha Hall, Deepa Bhojwani, Nirali Shah, Shannon Maude, Sara Zarnegar-Lumley, Allison Weisnicht, Keri Toner, Molly Thornock, Stephanie Thomas, Nicholas Tastet, Heather Symons, Jamie Shoag, Amanda Saraf, April Rahrig, Mahvish Rahim, Alexandra Prosser-Dombrowski, Thomas Pfeiffer, Hiren Patel, Megan Murphy, Lindsey Murphy, Amy Moskop, Giselle Moore-Higgs, Jordan Milner, Kevin McNerney, Cathy Lee-Miller, Mira Kohorst, Hannah Kinoshita, Elizabeth Krieger, Smitha Vasanna, Alex Hoover, Ashley Hinson, Miza Salim Hammoud, Darcy Hamill, Erin Goode, Kelly Faulk, Alejandra Escobar Vasco, Lyannette Elo, Anna Elias, Elizabeth Eom, Jennifer Drinkwine, J. Gregory Dolan, Laurie Davis, Roland Chu, Eliza Briscoe, Deepika Bhatla, Jill Beck, Abdulla Al-Mulla, Ibrahim Ahmed, Lena Winestone, Regina Myers

Blood (2025) 146 (Supplement 1): 4525.

https://doi.org/10.1182/blood-2025-4525

Published: 2025

Journal Articles

Mitochondrial DNA heteroplasmy and haplogroup variation in pediatric Acute Myeloid Leukemia

Audrey Zhu, Lusha Cao, Yang Xie, Hongbo Xie, Liming Pei, Tina Glisovic-Aplenc, Kelly Getz, Yimei Li, Richard Aplenc

Blood (2025) 146 (Supplement 1): 1720.

https://doi.org/10.1182/blood-2025-1720

Published: 2025

Journal Articles

Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy

Regina Myers, Yimei Li, Hongyan Liu, Alex Hoover, Laura Shinehouse, Ashley Hinson, Mira Kohorst, Anna Elias, Ella Keenan, Hannah Acres, Ibrahim Ahmed, Abdulla Al-Mulla, Laura Arthur, Jill Beck, Abigale Berry, Deepika Bhatla, Eliza Briscoe, Grace Chang, Roland Chu, Laurie Davis, J. Gregory Dolan, Lyannette Elo, Elizabeth Eom, Alejandra Escobar Vasco, Vanessa Fabrizio, Kelly Faulk, Victor Galan-Gomez, Erin Goode, Stephan Grupp, Anurekha Hall, Darcy Hamill, Smitha Vasanna, Hannah Kinoshita, Elizabeth Krieger, Cathy Lee-Miller, Katherine Lind, Jordan Milner, Giselle Moore-Higgs, Amy Moskop, Lindsey Murphy, Megan Murphy, Gabriella Nguyen, Maria Ortega, Hiren Patel, Antonio Perez, Thomas Pfeiffer, Alexandra Prosser-Dombrowski, Mahvish Rahim, April Rahrig, Shanti Ramachandran, Miza Salim Hammoud, Amanda Saraf, Jamie Shoag, Heather Symons, Nicholas Tastet, Stephanie Thomas, Molly Thornock, Keri Toner, Allison Weisnicht, Sara Zarnegar-Lumley, Nirali Shah, Shannon Maude, Jeremy Rubinstein, Troy Quigg, Deepa Bhojwani, Caitlin Elgarten

Blood (2025) 146 (Supplement 1): 3339.

https://doi.org/10.1182/blood-2025-3339

Published: 2025

Journal Articles

Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity

Blood (2025) 146 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2025-5169

Published: 2025

Journal Articles

Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study

Katherine Lind, Abigale Berry, Yimei Li, Hongyan Liu, Jeremy Rubinstein, Gabriella Nguyen, Vanessa Fabrizio, Anurekha Hall, Deepa Bhojwani, Troy Quigg, Shannon Maude, Nirali Shah, Maria Ortega, Abdulla Al-Mulla, Ibrahim Ahmed, Jill Beck, Deepika Bhatla, Eliza Briscoe, Roland Chu, Laurie Davis, J. Gregory Dolan, Jennifer Drinkwine, Anna Elias, Lyannette Elo, Elizabeth Eom, Kelly Faulk, Erin Goode, Darcy Hamill, Miza Salim Hammoud, Ashley Hinson, Alex Hoover, Hannah Kinoshita, Mira Kohorst, Elizabeth Krieger, Cathy Lee-Miller, Kevin McNerney, Jordan Milner, Amy Moskop, Giselle Moore-Higgs, Lindsey Murphy, Megan Murphy, Hiren Patel, Thomas Pfeiffer, Alexandra Prosser-Dombrowski, Mahvish Rahim, April Rahrig, Amanda Saraf, Jamie Shoag, Heather Symons, Nicholas Tastet, Stephanie Thomas, Molly Thornock, Keri Toner, Smitha Vasanna, Alejandra Escobar Vasco, Allison Weisnicht, Sara Zarnegar-Lumley, Lena Winestone, Regina Myers, Caitlin Elgarten

Blood (2025) 146 (Supplement 1): 6292.

https://doi.org/10.1182/blood-2025-6292

Published: 2025

Journal Articles

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Blood (2025) 146 (Supplement 1): 603.

https://doi.org/10.1182/blood-2025-603

Published: 2025

Journal Articles

Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity

Blood (2025) 146 (Supplement 1): 602.

https://doi.org/10.1182/blood-2025-602

Published: 2025

Journal Articles

CD123-directed chimeric antigen receptor T-cell (CART123) therapy for relapsed/refractory pediatric acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 1643.

https://doi.org/10.1182/blood-2025-1643

Published: 2025

Journal Articles

In Vivo Persistence and Function of CAR19 T-Cell Products for Pediatric B-Cell Acute Lymphoblastic Leukemia Are Impacted By Media, Cytokine Supplementation and Metabolite Bioavailability during Ex Vivo Manufacturing

Blood (2024) 144 (Supplement 1): 3473.

https://doi.org/10.1182/blood-2024-210324

Published: 2024

Journal Articles

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Allison Barz Leahy, Jennifer Brogdon, Lucy Cain, Amanda M. Dinofia, Joseph A. Fraietta, Richard Hanna, Stephan Kadauke, Raabia Khan, Yimei Li, Shannon L. Maude, Regina M. Myers, Laura Shinehouse, Anna Sparrow, Melissa Varghese, Lei Wang, Yongping Wang, Stephan A. Grupp

Blood (2024) 144 (Supplement 1): 3470.

https://doi.org/10.1182/blood-2024-204300

Published: 2024

Journal Articles

Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia

Daniel J. Zheng, Gary Hettinger, Lusha Cao, Caitlin W. Elgarten, Brian T. Fisher, Cody Gathers, Yuan-Shung V. Huang, Jennifer Ko, Kasey Leger, Yimei Li, Regina M. Myers, Hari K. Narayan, Jose Ortiz, Alix E. Seif, Richard Aplenc, Kelly D. Getz

Blood (2024) 144 (Supplement 1): 116.

https://doi.org/10.1182/blood-2024-208120

Published: 2024

Journal Articles

Hydroxyurea Initiation and Occurrence of Cerebrovascular Outcomes in Sickle Cell Disease

Aleksandra S Dain, Yimei Li, Sahal Master, Leslie Raffini, Kelly D. Getz, Janet L. Kwiatkowski

Blood (2024) 144 (Supplement 1): 2504.

https://doi.org/10.1182/blood-2024-194380

Published: 2024

Journal Articles

Clinical Factors Associated with Prolonged Cytopenias after CD19 Chimeric Antigen Receptor T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Adam Lamble, Emily M. Hsieh, Samuel John, Gregory Dolan, Hongyan Liu, Lee Chen, Jennifer Sheppard, Amanda M. DiNofia, Colleen Annesley, Stephan A. Grupp, Deepa Bhojwani, Rebecca A. Gardner, Lia Gore, Susan R Rheingold, Nirali N. Shah, Michael A. Pulsipher

Blood (2024) 144 (Supplement 1): 4827.

https://doi.org/10.1182/blood-2024-202027

Published: 2024

Journal Articles

Inconsistent Reporting and Definition of Time-to-Event Endpoints in CAR T Clinical Trials: A Review of the Literature and a Call for Harmonization

Connor B Grady, Yimei Li, Shannon L. Maude, Elizabeth O. Hexner, Noelle Frey, David L. Porter, Wei-Ting Hwang

Blood (2024) 144 (Supplement 1): 7805.

https://doi.org/10.1182/blood-2024-202597

Published: 2024

Journal Articles

Preinfusion Risk Factors for the Development of Severe Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Infusion in Pediatric Patients

Caroline Diorio, Regina M. Myers, Yimei Li, Amanda M. Dinofia, Hongyan Liu, Allison Barz Leahy, Haley Newman, Jillian Dolan, Zachary Martinez, Amira Elhachimi, Cassidy Mullen, Alexander Lai Li, John Kim, David T. Teachey, Shannon L. Maude, Jennifer McGuire, Stephan A. Grupp

Blood (2024) 144 (Supplement 1): 3454.

https://doi.org/10.1182/blood-2024-204993

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL

Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia

An evaluation of the relationship between abnormal myocardial perfusion and diastolic dysfunction in sickle cell disease using PET rest-stress myocardial perfusion imaging: Mypers

Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia

Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation

Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 study

Mitochondrial DNA heteroplasmy and haplogroup variation in pediatric Acute Myeloid Leukemia

Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy

Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity

Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity

CD123-directed chimeric antigen receptor T-cell (CART123) therapy for relapsed/refractory pediatric acute myeloid leukemia

In Vivo Persistence and Function of CAR19 T-Cell Products for Pediatric B-Cell Acute Lymphoblastic Leukemia Are Impacted By Media, Cytokine Supplementation and Metabolite Bioavailability during Ex Vivo Manufacturing

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia

Hydroxyurea Initiation and Occurrence of Cerebrovascular Outcomes in Sickle Cell Disease

Clinical Factors Associated with Prolonged Cytopenias after CD19 Chimeric Antigen Receptor T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Inconsistent Reporting and Definition of Time-to-Event Endpoints in CAR T Clinical Trials: A Review of the Literature and a Call for Harmonization

Preinfusion Risk Factors for the Development of Severe Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Infusion in Pediatric Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only